BillionToOne is trading 6.2% up now at $93.46 after recovering from the August 18 decline, primarily as biotech gains 3.73% following favorable investor response to Moderna’s positive Phase 3 personalized cancer-vaccine results.
- No new BillionToOne announcement dated August 19 was identified; its investor-relations page lists August 5 earnings as the latest release.
- Broader markets are modestly higher, but Nasdaq is mixed, making sector momentum more relevant than index direction.
- Trading volume and activity details are unavailable.